Challenges in Interpreting Survival Metrics in Clinical Trials: The Utility of Restricted Mean Survival Analyses

Itamar Averbuch; Avital Bareket-Samish; Daniel A. Goldstein; Sapir Eizenstein; Gal Markel; Eli Rosenbaum; Dror Limon; David Bomze; Ethan B. Ludmir; Tomer Meirson

doi:10.1016/j.ijrobp.2025.02.006

Challenges in Interpreting Survival Metrics in Clinical Trials: The Utility of Restricted Mean Survival Analyses

Itamar Averbuch, Avital Bareket-Samish, Daniel A. Goldstein, Sapir Eizenstein, Gal Markel, Eli Rosenbaum, Dror Limon, David Bomze, Ethan B. Ludmir, Tomer Meirson

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	224-233
Number of pages	10
Journal	International Journal of Radiation Oncology Biology Physics
Volume	122
Issue number	2
Early online date	18 Feb 2025
DOIs	https://doi.org/10.1016/j.ijrobp.2025.02.006
State	Published - 1 Jun 2025
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.ijrobp.2025.02.006

Cite this

Averbuch, I., Bareket-Samish, A., Goldstein, D. A., Eizenstein, S., Markel, G., Rosenbaum, E., Limon, D., Bomze, D., Ludmir, E. B., & Meirson, T. (2025). Challenges in Interpreting Survival Metrics in Clinical Trials: The Utility of Restricted Mean Survival Analyses. International Journal of Radiation Oncology Biology Physics, 122(2), 224-233. https://doi.org/10.1016/j.ijrobp.2025.02.006

@article{cf1aa6d96ee94b82b031c9b6c7225db7,

title = "Challenges in Interpreting Survival Metrics in Clinical Trials: The Utility of Restricted Mean Survival Analyses",

author = "Itamar Averbuch and Avital Bareket-Samish and Goldstein, {Daniel A.} and Sapir Eizenstein and Gal Markel and Eli Rosenbaum and Dror Limon and David Bomze and Ludmir, {Ethan B.} and Tomer Meirson",

year = "2025",

month = jun,

day = "1",

doi = "10.1016/j.ijrobp.2025.02.006",

language = "אנגלית",

volume = "122",

pages = "224--233",

journal = "International Journal of Radiation Oncology Biology Physics",

issn = "0360-3016",

publisher = "Elsevier Inc.",

number = "2",

}

Averbuch, I, Bareket-Samish, A, Goldstein, DA, Eizenstein, S, Markel, G, Rosenbaum, E, Limon, D, Bomze, D, Ludmir, EB & Meirson, T 2025, 'Challenges in Interpreting Survival Metrics in Clinical Trials: The Utility of Restricted Mean Survival Analyses', International Journal of Radiation Oncology Biology Physics, vol. 122, no. 2, pp. 224-233. https://doi.org/10.1016/j.ijrobp.2025.02.006

TY - JOUR

T1 - Challenges in Interpreting Survival Metrics in Clinical Trials

T2 - The Utility of Restricted Mean Survival Analyses

AU - Averbuch, Itamar

AU - Bareket-Samish, Avital

AU - Goldstein, Daniel A.

AU - Eizenstein, Sapir

AU - Markel, Gal

AU - Rosenbaum, Eli

AU - Limon, Dror

AU - Bomze, David

AU - Ludmir, Ethan B.

AU - Meirson, Tomer

PY - 2025/6/1

Y1 - 2025/6/1

UR - http://www.scopus.com/inward/record.url?scp=105000516290&partnerID=8YFLogxK

U2 - 10.1016/j.ijrobp.2025.02.006

DO - 10.1016/j.ijrobp.2025.02.006

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???

C2 - 39978692

AN - SCOPUS:105000516290

SN - 0360-3016

VL - 122

SP - 224

EP - 233

JO - International Journal of Radiation Oncology Biology Physics

JF - International Journal of Radiation Oncology Biology Physics

IS - 2

ER -

Challenges in Interpreting Survival Metrics in Clinical Trials: The Utility of Restricted Mean Survival Analyses

UN SDGs

Access to Document

Other files and links

Cite this